Clinical Trial Update: Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BN104 as post-HSCT maintenance therapy for acute leukemia, including patients with KMT2A rearrangements and NPM1 mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• BN104

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation | Phase 2 | Status: RECRUITING